Insider Transactions in Q3 2018 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2018
|
Alan Seth Krasner Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$34,000
$17.0 P/Share
|
|
Jul 20
2018
|
Versant Venture Capital V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,384,276
+31.1%
|
-
|
|
Jul 20
2018
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
353,180
+21.9%
|
$6,004,060
$17.93 P/Share
|
|
Jul 20
2018
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,384,278
+31.1%
|
-
|
|
Jul 20
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+14.92%
|
$6,800,000
$17.0 P/Share
|
|
Jul 20
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,880,305
+50.0%
|
-
|
|
Jul 20
2018
|
5 Am Ventures Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
115,000
+3.18%
|
$1,955,000
$17.0 P/Share
|
|
Jul 20
2018
|
5 Am Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
3,384,278
+31.1%
|
-
|